1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. KYMERA THERAPEUTICS INC
Kymera Therapeutics Inc XNAS: KYMR

Kymera Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' li...

Read More
71.16 -0.99 (-1.37%)
30.91% Fall from 52W High
963.0K
XNAS Volume

XNAS 28 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
6.7 / 100
Momentum Score
Technically Neutral
55.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
117
1Yr Price target upside is 65%
21 analysts

7

S

14

W

2

O

2

T

SWOT Analysis

Kymera Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..